Prevention of post-thrombotic syndrome: A case for new oral anticoagulant drugs or for heparins?

Journal of Thrombosis and Haemostasis

Volumn 10, Issue 8, 2012, Pages 1702-1703

  Baglin, T ^a  

^a ADDENBROOKE S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVITAMIN K; LOW MOLECULAR WEIGHT HEPARIN; THROMBIN ACTIVATABLE FIBRINOLYSIS INHIBITOR; WARFARIN;

ANTICOAGULANT THERAPY; BLOOD CLOT LYSIS; DEEP VEIN THROMBOSIS; DISEASE SEVERITY; FIBRINOLYSIS; HUMAN; INTERNATIONAL NORMALIZED RATIO; LETTER; POSTTHROMBOSIS SYNDROME; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); RECANALIZATION; RISK REDUCTION;

ADMINISTRATION, ORAL; ANTICOAGULANTS; HEPARIN; HUMANS; POSTTHROMBOTIC SYNDROME; VENOUS THROMBOSIS;

EID: 84865276746     PISSN: 15387933     EISSN: 15387836     Source Type: Journal    
DOI: 10.1111/j.1538-7836.2012.04806.x     Document Type: Letter

References (11)

1. Schulman S, Lindmarker P, Holmstrom M, Larfars G, Carlsson A, Nicol P, Svensson E, Ljungberg B, Viering S, Nordlander S, Leijd B, Jahed K, Hjorth M, Linder O, Beckman M. Post-thrombotic syndrome, recurrence, and death 10years after the first episode of venous thromboembolism treated with warfarin for 6weeks or 6months. J Thromb Haemostas, 2006; 4: 734-42.
2. Stain M, Schonauer V, Minar E, Bialonczyk C, Hirschl M, Weltermann A, Kyrle PA, Eichinger S. The post-thrombotic syndrome: risk factors and impact on the course of thrombotic disease. J Thromb Haemostas, 2005; 3: 2671-6.
3. van Dongen CJ, Prandoni P, Frulla M, Marchiori A, Prins MH, Hutten BA. Relation between quality of anticoagulant treatment and the development of the postthrombotic syndrome. J Thromb Haemost, 2005; 3: 939-42.
4. Ziegler S, Schillinger M, Maca TH, Minar E. Post-thrombotic syndrome after primary event of deep venous thrombosis 10 to 20years ago. Thromb Res, 2001; 101: 23-33.
5. Kahn SR, Shrier I, Julian JA, Ducruet T, Arsenault L, Miron MJ, Roussin A, Desmarais S, Joyal F, Kassis J, Solymoss S, Desjardins L, Lamping DL, Johri M, Ginsberg JS. Determinants and time course of the postthrombotic syndrome after acute deep venous thrombosis. Ann Intern Med, 2008; 149: 698-707.
6. Kahn SR, Kearon C, Julian JA, Mackinnon B, Kovacs MJ, Wells P, Crowther MA, Anderson DR, van Nguyen P, Demers C, Solymoss S, Kassis J, Geerts W, Rodger M, Hambleton J, Ginsberg JS. Predictors of the post-thrombotic syndrome during long-term treatment of proximal deep vein thrombosis. J Thromb Haemostas, 2005; 3: 718-23.
7. Hull RD, Pineo GF, Brant R, Liang J, Cook R, Solymoss S, Poon MC, Raskob G. Home therapy of venous thrombosis with long-term LMWH versus usual care: patient satisfaction and post-thrombotic syndrome. Am J Med, 2009; 122: 762-9. e3.
8. Hull RD, Liang J, Townshend G. Long-term low-molecular-weight heparin and the post-thrombotic syndrome: a systematic review. Am J Med, 2011; 124: 756-65.
9. Sweetland S, Green J, Liu B, Berrington de Gonzalez A, Canonico M, Reeves G, Beral V. Duration and magnitude of the postoperative risk of venous thromboembolism in middle aged women: prospective cohort study. Br Med J, 2009; 339: b4583.
10. Kearon C, Akl EA, Comerota AJ, Prandoni P, Bounameaux H, Goldhaber SZ, Nelson ME, Wells PS, Gould MK, Dentali F, Crowther M, Kahn SR. Antithrombotic Therapy for VTE Disease: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest, 2012; 141(2 Suppl): e419S-94S.
11. Keeling D, Baglin T, Tait C, Watson H, Perry D, Baglin C, Kitchen S, Makris M. Guidelines on oral anticoagulation with warfarin - fourth edition. Br J Haematol, 2011; 154: 311-24.